Neil Herskowitz insider trades: Avenue Therapeutics (ATXI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Neil reports to the SEC
and 8 more companies
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | ATXI | ↓ Sell | 23 | $2.00 | $46 | Direct | Dec 3, 2024 (1d) |
| May 6, 2021 | ATXI | ↑ Buy | 2,500 | $3.99 | $10K | Direct | May 7, 2021 (1d) |
| Feb 27, 2020 | ATXI | ↑ Buy | 2,561 | $8.23 | $21K | Direct | Mar 2, 2020 (4d) |
| Feb 25, 2020 | ATXI | ↑ Buy | 10,000 | $9.31 | $93K | Direct | Feb 25, 2020 (0d) |
| Jun 18, 2019 | ATXI | ↑ Buy | 5,000 | $5.86 | $29K | Direct | Jun 19, 2019 (1d) |
| Apr 15, 2019 | ATXI | ↑ Buy | 1,000 | $4.52 | $5K | Direct | Apr 15, 2019 (0d) |
| Mar 29, 2019 | ATXI | ↑ Buy | 2,000 | $5.11 | $10K | Direct | Mar 29, 2019 (0d) |
| Feb 25, 2019 | ATXI | ↑ Buy | 5,000 | $5.46 | $27K | Direct | Feb 25, 2019 (0d) |
| Feb 5, 2019 | ATXI | ↑ Buy | 8,850 | $5.88 | $52K | Direct | Feb 6, 2019 (1d) |
| Jan 30, 2019 | ATXI | ↑ Buy | 650 | $5.91 | $4K | Direct | Feb 1, 2019 (2d) |
| Jan 29, 2019 | ATXI | ↑ Buy | 10,000 | $5.90 | $59K | Direct | Jan 30, 2019 (1d) |
| Nov 23, 2018 | MBIO | ↑ Buy | 1,000 | $3.96 | $4K | Direct | Dec 7, 2018 (14d) |
| Apr 25, 2018 | ATXI | ↑ Buy | 1,000 | $3.80 | $4K | Direct | Apr 25, 2018 (0d) |
| Oct 17, 2017 | ATXI | ↑ Buy | 1,000 | $5.01 | $5K | Direct | Oct 18, 2017 (1d) |
| Oct 9, 2017 | ATXI | ↑ Buy | 500 | $5.24 | $3K | Direct | Oct 10, 2017 (1d) |
| Dec 6, 2012 | TGTX | ↑ Buy | 1,000 | $2.00 | $2K | Indirect | Dec 12, 2012 (6d) |
| Apr 24, 2007 | IVPH.OB | ↑ Buy | 18,315 | $2.73 | $50K | Held by Riverside Contracting LLC | Apr 26, 2007 (2d) |
| Mar 30, 2007 | MHA | ↑ Buy | 55,555 | $0.90 | $50K | By Riverside Contracting, LLC | Apr 9, 2007 (10d) |
| Jul 18, 2006 | MHA | ↑ Buy | 10,000 | $0.68 | $7K | Direct | Jul 31, 2006 (13d) |
| Jan 10, 2006 | MHA | ↑ Buy | 14,200 | $1.30 | $18K | By Riverside Contracting, LLC | Jan 12, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Neil Herskowitz's insider trades
Neil Herskowitz is a director at Avenue Therapeutics (ATXI). Since Jan 10, 2006, Neil has reported 19 open-market purchases worth $453K and 1 sale worth $46 on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (40 filings), other transactions (5 filings), conversions (3 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATXI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.